ImmunoGen, Inc.
IMGN · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$223 | -$223 | -$44 | -$104 |
| Dep. & Amort. | $2 | $2 | $2 | $4 |
| Deferred Tax | $0 | $0 | -$1 | $2 |
| Stock-Based Comp. | $26 | $26 | $14 | $14 |
| Change in WC | -$26 | -$26 | -$5 | $26 |
| Other Non-Cash | -$9 | -$9 | -$45 | -$31 |
| Operating Cash Flow | -$230 | -$230 | -$79 | -$88 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$1 | -$1 | -$3 |
| Net Acquisitions | $0 | $0 | $1 | $2 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$1 | -$1 | $1 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $26 | $357 | $0 | $3 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $28 | $356 | $196 | $3 |
| Financing Cash Flow | $28 | $356 | $196 | $3 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$204 | -$204 | $118 | -$86 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $479 | $479 | $176 | $262 |
| End Cash | $275 | $275 | $294 | $176 |
| Free Cash Flow | -$231 | -$231 | -$80 | -$91 |